Julie Cooke

Companies

• Neurocrine BiosciencesChief Human Resources Officer May 17, 2019 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Neurocrine Biosciences NBIX24,025 shares²$3.3M at $137.36Sep 11, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 11, 2026Shares withheld for tax 1,936 shares at $156.22 of Neurocrine Biosciences²
• Sep 11, 2026Granted 3,587 shares of Neurocrine Biosciences²
• Jun 2, 2026Sold 3,520 shares at $158.59 of Neurocrine Biosciences³
• Jun 2, 2026Sold 9,521 shares at $157.62 of Neurocrine Biosciences³
• Jun 2, 2026Sold 4,216 shares at $156.77 of Neurocrine Biosciences³
• Jun 2, 2026Sold 5,466 shares at $155.46 of Neurocrine Biosciences³
• Jun 2, 2026Sold 14,214 shares at $154.83 of Neurocrine Biosciences³
• Jun 2, 2026Exercised options 24,965 shares at $81.49 of Neurocrine Biosciences³
• Feb 13, 2026Shares withheld for tax 5,378 shares at $124.12 of Neurocrine Biosciences⁴
• Feb 13, 2026Granted 9,968 shares of Neurocrine Biosciences⁴
• Feb 13, 2026Shares withheld for tax 815 shares at $124.12 of Neurocrine Biosciences⁴
• Feb 13, 2026Exercised options 1,510 shares of Neurocrine Biosciences⁴
• Feb 13, 2026Shares withheld for tax 756 shares at $124.12 of Neurocrine Biosciences⁴
• Feb 13, 2026Exercised options 1,401 shares of Neurocrine Biosciences⁴
• Feb 12, 2026Shares withheld for tax 749 shares at $123.10 of Neurocrine Biosciences⁴
• Feb 12, 2026Exercised options 1,387 shares of Neurocrine Biosciences⁴
• Jan 31, 2026Shares withheld for tax 997 shares at $136.06 of Neurocrine Biosciences⁵
• Jan 31, 2026Exercised options 1,741 shares of Neurocrine Biosciences⁵
• May 16, 2025Exercised options 6,468 shares at $61.82 of Neurocrine Biosciences⁶
• Feb 13, 2025Sold 755 shares at $116.80 of Neurocrine Biosciences⁷
• Feb 13, 2025Exercised options 1,401 shares of Neurocrine Biosciences⁷
• Feb 13, 2025Sold 796 shares at $116.77 of Neurocrine Biosciences⁷
• Feb 13, 2025Exercised options 1,509 shares of Neurocrine Biosciences⁷
• Feb 10, 2025Sold 700 shares at $118.28 of Neurocrine Biosciences⁸
• Feb 8, 2025Exercised options 1,329 shares of Neurocrine Biosciences⁸